Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Drug development research

Showing results (941-950 of 1,350) with videos related to

Pageof 135
Sort By:
Drug Development Research|December 11, 2024
Design and Discovery of New Dual Carbonic Anhydrase IX and VEGFR-2 Inhibitors Based on the Benzenesulfonamide-Bearing 4-Thiazolidinones/2,4-Thiazolidinediones ScaffoldMerve Zengin, Oya Unsal Tan, Suna Sabuncuoglu, et al.
Drug Development Research|January 1, 2025
Adenosine A<sub>1</sub> and A<sub>3</sub> Receptors: Distinct CardioprotectionBruce T Liang, Douglas Stewart, Kenneth A Jacobson
Drug Development Research|December 11, 2023
Exploring the potential of radiolabeled duramycin as an infection imaging probeAnuj Kumar, Jyotsna Bhatt Mitra, Elina Khatoon, et al.
Drug Development Research|December 6, 2023
Covalent inhibitors: An ambitious approach for the discovery of newer oncotherapeuticsRameshwar S Cheke, Prashant S Kharkar
Drug Development Research|February 13, 2024
Influence of β-catenin signaling on neurogenesis in neuropsychiatric disorders: Anxiety and depressionRana A El-Kadi, Noha F AbdelKader, Hala F Zaki, et al.
Drug Development Research|February 13, 2024
Drug upgrade: A complete methodology from old drug to new chemical entities using Nematic Protein Organization TechniqueJudith Eschbach, Alain Wagner, Corinne Beahr, et al.
Drug Development Research|January 19, 2024
1,3-Dialkylxanthine Derivatives Having High Potency as Antagonists at Human A<sub>2B</sub> Adenosine ReceptorsKenneth A Jacobson, Ad P IJzerman, Joel Linden
Drug Development Research|January 19, 2024
Recent Developments in Selective Agonists and Antagonists Acting at Purine and Pyrimidine ReceptorsKenneth A Jacobson, Fumio Suzuki
Drug Development Research|January 29, 2024
Purinoceptors in the Central Nervous SystemT V Dunwiddie, M P Abbracchio, N Bischofberger, et al.
Drug Development Research|April 3, 2024
New insights into the anticancer therapeutic potential of icaritin and its synthetic derivativesOctavio Daniel Reyes-Hernández, Gabriela Figueroa-González, Laura Itzel Quintas-Granados, et al.
Pageof 135

Showing results (941-950 of 1,350) with videos related to

Sort By:
Pageof 135
Drug Development Research|December 11, 2024
Design and Discovery of New Dual Carbonic Anhydrase IX and VEGFR-2 Inhibitors Based on the Benzenesulfonamide-Bearing 4-Thiazolidinones/2,4-Thiazolidinediones ScaffoldMerve Zengin, Oya Unsal Tan, Suna Sabuncuoglu, et al.
Drug Development Research|January 1, 2025
Adenosine A<sub>1</sub> and A<sub>3</sub> Receptors: Distinct CardioprotectionBruce T Liang, Douglas Stewart, Kenneth A Jacobson
Drug Development Research|December 11, 2023
Exploring the potential of radiolabeled duramycin as an infection imaging probeAnuj Kumar, Jyotsna Bhatt Mitra, Elina Khatoon, et al.
Drug Development Research|December 6, 2023
Covalent inhibitors: An ambitious approach for the discovery of newer oncotherapeuticsRameshwar S Cheke, Prashant S Kharkar
Drug Development Research|February 13, 2024
Influence of β-catenin signaling on neurogenesis in neuropsychiatric disorders: Anxiety and depressionRana A El-Kadi, Noha F AbdelKader, Hala F Zaki, et al.
Drug Development Research|February 13, 2024
Drug upgrade: A complete methodology from old drug to new chemical entities using Nematic Protein Organization TechniqueJudith Eschbach, Alain Wagner, Corinne Beahr, et al.
Drug Development Research|January 19, 2024
1,3-Dialkylxanthine Derivatives Having High Potency as Antagonists at Human A<sub>2B</sub> Adenosine ReceptorsKenneth A Jacobson, Ad P IJzerman, Joel Linden
Drug Development Research|January 19, 2024
Recent Developments in Selective Agonists and Antagonists Acting at Purine and Pyrimidine ReceptorsKenneth A Jacobson, Fumio Suzuki
Drug Development Research|January 29, 2024
Purinoceptors in the Central Nervous SystemT V Dunwiddie, M P Abbracchio, N Bischofberger, et al.
Drug Development Research|April 3, 2024
New insights into the anticancer therapeutic potential of icaritin and its synthetic derivativesOctavio Daniel Reyes-Hernández, Gabriela Figueroa-González, Laura Itzel Quintas-Granados, et al.
Pageof 135